CAS: 1218942-37-0 - 2-(2-Chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione

Formel: C₂₁H₁₉ClN₄O₂

InChl: InChI=1S/C21H19ClN4O2/c1-24(2)14-8-6-7-13(11-14)20-19-16(12-18(27)25(20)3)23-26(21(19)28)17-10-5-4-9-15(17)22/h4-12,23H,1-3H3

InChI Key: InChIKey=RGYQPQARIQKJKH-UHFFFAOYSA-N

SMILES: O=C1C=C2NN(C(=O)C2=C(C=3C=CC=C(C3)N(C)C)N1C)C=4C=CC=CC4Cl

1H-Pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione, 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-

CAS: 1218942-37-0

• Formel: C₂₁H₁₉ClN₄O₂
• Reinheit: 99%
• Farbe und Form: Solid
• Molekulargewicht: 394.8542

Setanaxib

CAS: 1218942-37-0

Setanaxib (GKT137831) is a potent, specific dual NADPH oxidase (NOX1/4) inhibitor.

• Formel: C₂₁H₁₉ClN₄O₂
• Reinheit: 99.66%
• Farbe und Form: Solid
• Molekulargewicht: 394.85

2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione

CAS: 1218942-37-0

• Reinheit: 95.0%
• Farbe und Form: Solid
• Molekulargewicht: 394.8599853515625

GKT-137831

CAS: 1218942-37-0

NADPH oxidase inhibitor; anti-inflammatory

• Formel: C₂₁H₁₉ClN₄O₂
• Reinheit: Min. 95%
• Farbe und Form: Off-White Powder
• Molekulargewicht: 394.85 g/mol

2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione-d3

CAS: 1218942-37-0

• Formel: C₂₁D₃H₁₆ClN₄O₂
• Farbe und Form: Neat
• Molekulargewicht: 397.873

2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione

CAS: 1218942-37-0

• Formel: C₂₁H₁₉ClN₄O₂
• Farbe und Form: Neat
• Molekulargewicht: 394.854